Global Tuberculosis Report 2017. WHO. (2017)

immage

WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This is done in the context of recommended global TB strategies and targets endorsed by WHO’s Member States and broader development goals set by the United Nations.

 

Keywords: SDGs, TB, ART, treatment, prevention, diagnosis

 


Download Full Report and Executive Summary

Factsheet: Unitaid and Tuberculosis. UNITAID. (2017)

immage

Unitaid invests in new ways to prevent, diagnose and treat tuberculosis (TB) more quickly, more cheaply and more effectively. Some of our interventions include: accelerating diagnosis. The most widely used test for TB is to take a patient’s sputum sample and identify the bacterium under a microscope. The bacteria are then grown in a dish containing anti-TB drugs to see if they are resistant to the most commonly used drugs to treat TB.

 


Keywords: HIV, TB, diagnosis, treatment, drug resistant

 

 

Download Publication

Global Investments in Tuberculosis Research and Development: Past, Present, and Future. WHO. (2017)

immage

This document aims to articulate a coherent vision of the research needs to end TB and elaborates on the funding and structural requirements that are necessary to operationalize this vision. It describes how some of the research funded in the past has delivered benefits to patients and influenced policy- and decision-making, but also how little is being invested in TB R&D in comparison with other diseases, such as HIV and malaria, that also affect poor populations. The paper shows that, despite significant progress, previous investments were not sufficient to warrant success in tackling difficult challenges, such as multidrug-resistant TB (MDR-TB), expedited development of new and improved tools, and effective deployment of such tools.


Keywords: TB, public health, funding, drug-resistant

 

Download Publication

Annual Report 2015. National Tuberculosis Programme, Myanmar. (2017)

immage

National Tuberculosis Programme (NTP) is functioning with Regional/State TB centers and 101 vertical TB teams. The NTP covered all 325 townships with DOTS strategy in November 2003 and all 330 townships including five new townships established in NayPyiTaw Union Territory in 2011. "Stop TB Strategy" was introduced in 2007 aiming to achieve the targets linked to the Millennium Development Goals (MDGs) by 2015.

 


Keywords: TB/HIV, drug resistant, treatment, testing

 

Download Publication

Key Populations Brief: Indigenous Peoples. Stop TB Partnership. (2017)

immage

The world’s 370 million indigenous peoples face a plethora of issues caused by displacement, dispossession, loss of livelihood, systematic racism and abuse, and lack of recognition (1–4). Further hindering an adequate response to these challenges, there is a pervasive lack of data about indigenous peoples concerning health and other key development indicators. Data that are available show a prevalence of extreme poverty and severe health disparities that include tuberculosis (TB).

 

Keywords: TB, health, diagnosis, treatment, data

 

 

Download Publication

90-(90)-90 the Tuberculosis Report for Heads of State and Governments: Global Plan to End TB 2016-2020. Kazi F and Andino SG. (2017)

immage

This report is the first in a series produced by the Stop TB Partnership. The goal is to assess the status of country TB programmes in terms of the Global Plan’s 90-(90)-90 targets and to provide a baseline for monitoring progress over the next 5 years. Currently, the 30 high TB and drug-resistant TB (DR-TB) burden countries that account for almost 80% of the global burden exhibit the biggest gaps in the areas of diagnosis for TB and DR-TB, and the provision of preventive therapy (PT). Moreover, monitoring the uptake of TB services in key populations remains a challenge due to the limited availability and disaggregation of data.


Keywords: TB, HIV, ART, drug-resistant, treatment

 

 

Download Publication

Statement on the Use of Child-friendly Fixed-dose Combinations for the Treatment of TB in Children. WHO and UNICEF. (2017)

immage

The World Health Organization (WHO) and UNICEF has issued a joint statement, urging all National TB Programmes to replace the previously used medicines for children weighing less than 25 kg with the child-friendly dispersible TB fixed-dose combinations (FDCs) at the soonest possible time. WHO and UNICEF advise against continued usage of the old sub-optimally dosed FDCs or adult formulations (crushed tablets), which may lead to under or over-dosing, unfavourable treatment outcomes, and high likelihood of contributing to the development of drug resistance. 


Keywords: TB, treatment, children, drug resistance

 

Download Publication

Data for Action for Tuberculosis Key, Vulnerable and Underserved Populations - Working Document. Mok P, Turusbekova N and Johnston L. (2017)

immage

This document provides a framework for countries to accelerate TB responses among key populations. The framework describes key principles and a process that countries can utilize and adapt to design and implement their TB programmes for key populations. It has been primarily designed for governments and civil society service providers and other stakeholders to take actions against TB among key populations. Other relevant stakeholders include national health coordination bodies and development partners and other implementers that support country efforts to carry out TB services for key populations.

 

Keywords: TB, treatment, diagnosis, testing

 

 

Download Publication

Out of Step in EECA: TB Policies in 8 Countries in Eastern Europe and Central Asia. Stop TB Partnership. (2017)

immage

Although it can be prevented and successfully treated, tuberculosis (TB) is the world’s deadliest infectious disease. In Eastern Europe and Central Asia (EECA), conditions are ripe for TB proliferation, with suboptimal TB diagnosis and treatment, poor treatment adherence rates, limited health care in prisons, and high rates of HIV infection and injection drug use, all against a backdrop of weak health care systems. In 2015, most of the 323,000 new TB cases and the 32,000 deaths due to TB in the WHO European Region occurred in EECA. In 2015, an estimated one in five MDR-TB cases globally occurred in the European Region.


Keywords: TB, prevention, testing, treatment

 

Download Publication

Ethics Guidance for the Implementation of the TB Strategy. WHO. (2017)

immage

The World Health Organization End TB Strategy is fully aligned with the framework of the Sustainable Development Goals (SDGs). Both require due attention to equity, human rights and ethics. In fact, “protecting human rights, ethics and equity” is one of the four key principles of the WHO End TB Strategy. The SDG agenda itself is inspired by a simple motto: “Leave no one behind”. Ensuring that these essential principles guide the implementation of the End TB Strategy is a must, especially when tuberculosis (TB) is rampant among the most vulnerable and marginalized populations everywhere in the world.


Keywords: human rights, care and prevention, treatment, children, prisoners, migrants, health care

 

Download Publication

Pages

database
Highlighted publications
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_PWID_PWUD_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_FEW_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/DataHub_TB-HIV_Fact_Sheet_2018.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Monitoring_2018.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Annual_report_2016-17.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_What_New_in_Treatment_Monitoring_Viral_Load_and_CD4_Testing_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_IBBS_2016-17.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_Mapping_Key_Populations_2015-16.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017_Data_2017_en.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_2017_Global_AIDS_Monitoring_2016.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal-IBBS-FIDU-Kathmandu-valley-RI-2016.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/2015_Size_Estimation_of_Key_Affected_Populations_in_Philippines.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Assessment_of_Decentralization_of_ART_in_MMR_2016.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-2016-prevention-gap-report_en.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Implementing_comprehensive_HIV_and_STI_programmes_with_transgender_people_2016.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_cities_ending_the_aids_epidemic_2016.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Philippines_2015_IHBSS_Fact_Sheets_Nov2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events